Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00427206 · ClinicalTrials.gov registry record · Phase 4
Hepatic Function in Alcoholics Following 5 Days of Acetaminophen Dosing
A Phase 4 study of Alcohol-Related Disorders, sponsored by Denver Health and Hospital Authority.
- Completed
- Registry status
- Phase 4
- Development phase
- 181
- Enrollment target
- 2
- Study locations
NCT00427206: Completed Phase 4 study of Alcohol-Related Disorders, sponsored by Denver Health and Hospital Authority.
NCT00427206 is a Phase 4 study of Alcohol-Related Disorders that has completed, run by Denver Health and Hospital Authority. The registered enrollment target is 181 participants, below the 1,756-participant average among 23 other Alcohol-Related Disorders trials with a reported enrollment target (90% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00427206, a Phase 4 study of Alcohol-Related Disorders, has completed, sponsored by Denver Health and Hospital Authority.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 181 participants
- Enrollment target
- 2
- Study locations
Study Summary
The study objective was to determine if liver injury develops in alcoholic patients during or following 5 days of therapeutic acetaminophen dosing. Volunteers were recruited from two community detoxification centers to take either acetaminophen (4g/day) or placebo for 5 consecutive days. All subjects were monitored an additional two days following the dosing period. The primary measures were aminotransferase measures taken at baseline and Days 2, 4, 6 and 7. We hypothesized that there would be no difference in aminotransferase means between the groups at any study period.
Conditions Studied
Interventions
- DRUG placebo
- DRUG acetaminophen (4g/day)
Study Locations (2)
Colorado
- Denver CARES - Denver
Ontario
- Centre for Addiction and Mental Health - Toronto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 181 participants |
| Start Date | 2004-11 |
| Est. Completion | 2005-12 |
| Phase | Phase 4 |
What the finished NCT00427206 record still lists
NCT00427206 is an interventional study that assigns participants to a tested intervention. The registered 181 participants enrollment target is mid-sized for trials with a published cap, below the 1,756-participant average among 23 other Alcohol-Related Disorders trials with a reported enrollment target (90% lower).
The record links to 1 condition, with Alcohol-Related Disorders appearing as the primary indexed condition, and to 2 interventions - of which placebo is the first listed.
NCT00427206 reports a single indexed study location in Colorado, Ontario.
Frequently Asked Questions
What is clinical trial NCT00427206 about?
NCT00427206 is a clinical study titled "Hepatic Function in Alcoholics Following 5 Days of Acetaminophen Dosing". The study objective was to determine if liver injury develops in alcoholic patients during or following 5 days of therapeutic acetaminophen dosing. Volunteers were recruited from two community detoxification centers to take either acetaminophen (4g/day) or placebo for 5 consecutive days. All subject...
What is the current status of trial NCT00427206?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 181 participants. The study started on 2004-11. Estimated completion is 2005-12.
What conditions does trial NCT00427206 study?
This clinical trial studies the following conditions: Alcohol-Related Disorders.
What interventions are being tested in trial NCT00427206?
The interventions under investigation include: placebo (DRUG), acetaminophen (4g/day) (DRUG).
Who is sponsoring clinical trial NCT00427206?
This trial is sponsored by Denver Health and Hospital Authority, which has 73 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00427206 being conducted?
This trial has 2 study locations across Colorado, Ontario. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcohol-Related Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00427206's enrollment target sits among peer trials
181 10th of 23 higher than 14 of 23 other Alcohol-Related Disorders trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alcohol-Related Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Naltrexone Treatment of Alcohol Abuse in Schizophrenia
COMPLETED · Phase 4
-
External Facilitation to Increase Prescribing of AUD Medications in the Psychiatric Setting
RECRUITING · NA
-
Intervention to Increase Intention to Change Alcohol/Tobacco Use in Veterans With Chronic Disease
RECRUITING · Phase 3
-
Characterization Imaging Instruments in Alcoholics and Non-Alcoholics
RECRUITING
-
Feasibility of the 5-Step Method in the U.S.
RECRUITING · NA
-
COVID-19 Pandemic Impact on Alcohol (PIA) - A Natural History Study
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04578392 · 181 participants · NA
MeSenteric SpAring Versus High Ligation Ileocolic Resection for the Prevention of REcurrent Crohn's DiseaSe (SPARES)
- NCT05597891 · 181 participants · NA
Endovascular Engineering ENGULF Study
- NCT03897998 · 182 participants · Phase 2
Neural Correlates of Hypoalgesia Driven by Observation
- NCT04300556 · 182 participants · Phase 1
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia